CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients
Claudia Windmüller(Technical University of Munich), Holger Bronger(Technical University of Munich), Manfred Schmitt(Saarland University), Barbara Schmalfeldt(Universität Hamburg), Marion Kiechle(Klinikum rechts der Isar), Stefanie Avril(Cornell University), Melanie Boxberg(Starnberg Hospital), T Dawidek(Technical University of Munich), Daniela Zech(Technical University of Munich)
Cited by 34
Related Papers
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
|Nature Genetics|2010|734
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
|Clinical Cancer Research|2012|124
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
|Gynecologic Oncology|2019|121